Literature DB >> 27022332

Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.

Antonietta Gigante1, Giuseppe Barilaro1, Biagio Barbano1, Antonella Romaniello2, Francesca Di Mario1, Silvia Quarta1, Maria Ludovica Gasperini1, Gianluca Di Lazzaro Giraldi1, Alessandro Laviano1, Antonio Amoroso1, Rosario Cianci1, Edoardo Rosato1.   

Abstract

BACKGROUND: Cardiorenal syndrome type 5 (CRS-5) includes a group of conditions characterized by a simultaneous involvement of the heart and kidney in the course of a systemic disease. Systemic sclerosis (SSc) is frequently involved in the etiology of acute and chronic CRS-5 among connective tissue diseases. In SSc patients, left ventricular mass (LVM) can be used as a marker of nutritional status and fibrosis, while altered intrarenal hemodynamic parameters are suggestive of early kidney involvement.
METHODS: Forty-two consecutive patients with a diagnosis of SSc without cardiac and/or renal impairment were enrolled to assess whether cardiac muscle mass can be related to arterial stiffness. Thirty subjects matched for age and sex were also enrolled as healthy controls (HC). All patients performed echocardiography and renal ultrasound.
RESULTS: Doppler indices of intrarenal stiffness and echocardiographic indices of LVM were significantly increased in SSc patients compared to HC. A positive correlation exists between LVM/body surface area and pulsatile index (p < 0.05, r = 0.36), resistive index (p < 0.05, r = 0.33) and systolic/diastolic ratio (p < 0.05, r = 0.38). Doppler indices of intrarenal stiffness and LVM indices were significantly higher in SSc patients with digital ulcers than in SSc patients without a digital ulcer history.
CONCLUSIONS: SSc is characterized by the presence of microvascular and multiorgan injury. An early cardiac and renal impairment is very common. LVM and intrarenal arterial stiffness can be considered as early markers of CRS onset. The clinical use of these markers permits a prompt identification of organ damage. An early diagnosis allows the appropriate setting of pharmacological management, by slowing disease progression.
© 2016 S. Karger AG, Basel.

Entities:  

Keywords:  Cardiorenal syndrome; Doppler ultrasound; Echocardiography; Left ventricular mass; Renal resistive index; Systemic sclerosis

Year:  2016        PMID: 27022332      PMCID: PMC4798274          DOI: 10.1159/000442996

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  27 in total

Review 1.  Pathogenesis of Raynaud's phenomenon.

Authors:  A L Herrick
Journal:  Rheumatology (Oxford)       Date:  2005-03-01       Impact factor: 7.580

2.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

Review 3.  The cardiorenal problem.

Authors:  Emiliy Pollock; Albina Nowak
Journal:  Swiss Med Wkly       Date:  2014-12-04       Impact factor: 2.193

4.  QTc interval prolongation in systemic sclerosis: correlations with clinical variables.

Authors:  E Rosato; A Gigante; M Liberatori; M L Gasperini; L Sardo; A Amoroso; L Tubani
Journal:  Int J Cardiol       Date:  2014-12-24       Impact factor: 4.164

5.  Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward.

Authors:  Antonietta Gigante; Marta Liberatori; Maria Ludovica Gasperini; Liborio Sardo; Francesca Di Mario; Barbara Dorelli; Biagio Barbano; Edoardo Rosato; Filippo Rossi Fanelli; Antonio Amoroso
Journal:  Cardiorenal Med       Date:  2014-05-06       Impact factor: 2.041

6.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

7.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

8.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

Authors:  W P Follansbee; T R Miller; E I Curtiss; J E Orie; R L Bernstein; J M Kiernan; T A Medsger
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

9.  Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables.

Authors:  Edoardo Rosato; Stefania Maione; Antonio Vitarelli; Anna Giunta; Luca Fontanella; Laura Tanturri de Horatio; Francesco Cacciatore; Michele Proietti; Simonetta Pisarri; Felice Salsano
Journal:  Rheumatol Int       Date:  2008-12-28       Impact factor: 2.631

Review 10.  Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.